Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,896 | 25,631 | 26,169 | 13,343 | N/A |
| Marketable Securities | N/A | 0 | N/A | 3,000 | N/A |
| Receivables | 50 | 2,096 | 331 | 367 | N/A |
| Inventories | 2,661 | 1,703 | 1,951 | 2,031 | N/A |
| Other current assets | 819 | 235 | 257 | 264 | 0 |
| TOTAL | $106,426 | $29,665 | $28,708 | $19,005 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 5,210 | 5,334 | 5,637 | 5,831 | N/A |
| Intangibles | 17,046 | 17,420 | 17,793 | 18,167 | 0 |
| Other Non-Current Assets | 2,427 | 3,471 | 2,486 | 2,227 | 0 |
| TOTAL | $24,683 | $26,225 | $25,916 | $26,225 | $N/A |
| Total Assets | $131,109 | $55,890 | $54,624 | $45,230 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,775 | 3,257 | 3,495 | 1,653 | N/A |
| Accounts payable and accrued liabilities | 2,376 | 1,333 | 569 | 1,257 | 0 |
| Accrued Expenses | 5,086 | 2,430 | 2,219 | 2,715 | N/A |
| TOTAL | $13,237 | $7,020 | $6,283 | $5,625 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,579 | 31,198 | 26,124 | 23,121 | N/A |
| Other Non-Current Liabilities | 353 | 4,290 | 4,033 | 2,545 | 0 |
| TOTAL | $30,855 | $37,627 | $32,513 | $28,238 | $N/A |
| Total Liabilities | $44,092 | $44,647 | $38,796 | $33,863 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,943 | 15,836 | 9,689 | N/A | N/A |
| Common Shares | 16 | 1 | 1 | 1 | N/A |
| Retained earnings | -107,681 | -98,076 | -91,193 | -83,614 | N/A |
| Other shareholders' equity | 0 | 104,249 | 102,088 | 90,149 | 0 |
| TOTAL | $87,017 | $11,243 | $15,828 | $11,367 | $N/A |
| Total Liabilities And Equity | $131,109 | $55,890 | $54,624 | $45,230 | $0 |